Second Primary Differentiated Thyroid Carcinoma in Adult Cancer Survivors: A SEER Database Analysis

甲状腺癌 肿瘤科 医学 内科学 癌症 甲状腺癌 原发性癌症 甲状腺 数据库 计算机科学
作者
Jianhua Feng,Caixiu Wu,Fei Shen,Wen-song Cai,Bo Xu
出处
期刊:The Journal of Clinical Endocrinology and Metabolism [The Endocrine Society]
被引量:1
标识
DOI:10.1210/clinem/dgae501
摘要

Abstract Context Adult cancer survivors are at a heightened risk for secondary primary differentiated thyroid carcinoma (2-DTC). The characteristics and outcomes of 2-DTC remain poorly understood. Objective We aimed to explore the characteristics and outcomes of 2-DTC. Methods We retrospectively analyzed data from the Surveillance, Epidemiology, and End Results (SEER) database (2000-2017). 2-DTC was divided into 25 subgroups based on prior primary malignancies (PPMs). Baseline characteristics were compared using the chi-square test. Multivariable logistic analysis was used to identified if PPMs were associated with aggressive DTC characteristics. DTC-specific and cancer-specific mortality were analyzed using a univariable and multivariable competing risk regression model. Results There were 138 555 1-DTC and 9253 2-DTC patients identified. 2-DTC patients were predominantly older, male, and White compared to first primary DTC (1-DTC) (all P < .05). In multivariable logistic regression analysis, only 4 types of PPMs were associated with higher rates of DTC aggressive characteristics, while 19 types exhibited lower rates (all P < .05). In multivariable competing risk analysis, 2-DTC showed no mortality risk in stages I (SHR: 1.16; 95% CI, 0.65-2.07) and II (SHR: 0.67; 95% CI, 0.45-1.01), but a protective role in stages III (SHR: 0.47; 95% CI, 0.27-0.83) and IV (SHR: 0.72; 95% CI, 0.52-0.99). Most PPMs that developed into 2-DTC had a lower risk of DTC-specific death than 1-DTC, but many PPMs had a higher risk of cancer-specific death. Conclusion Given the characteristics and outcomes of 2-DTC, aggressive treatment for 2-DTC, particularly for PPM with a high mortality risk, may not be advisable.

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
1秒前
西咪发布了新的文献求助10
1秒前
1秒前
周周发布了新的文献求助20
1秒前
青松发布了新的文献求助10
1秒前
1秒前
xuerui完成签到,获得积分20
1秒前
小分队发布了新的文献求助10
1秒前
2秒前
2秒前
2秒前
2秒前
gtxy完成签到 ,获得积分10
3秒前
3秒前
DeepFancy发布了新的文献求助10
4秒前
9702完成签到 ,获得积分10
4秒前
4秒前
4秒前
cjw123发布了新的文献求助30
4秒前
执着无声发布了新的文献求助10
4秒前
yesmider发布了新的文献求助10
5秒前
希望天下0贩的0应助lucky采纳,获得10
5秒前
在水一方应助小知了采纳,获得10
5秒前
核桃发布了新的文献求助10
6秒前
木子发布了新的文献求助20
6秒前
彭于晏应助风中黎昕采纳,获得10
6秒前
Daut应助风中黎昕采纳,获得10
6秒前
NN应助LZ采纳,获得10
6秒前
大模型应助风中黎昕采纳,获得10
6秒前
lyxxll发布了新的文献求助10
6秒前
曹坤发布了新的文献求助10
7秒前
7秒前
CipherSage应助外向老太采纳,获得10
7秒前
7秒前
8秒前
南宫傻姑完成签到,获得积分10
8秒前
Sir.夏季风完成签到,获得积分10
8秒前
8秒前
跳跃的如豹完成签到 ,获得积分10
9秒前
从容的胡萝卜应助Saint采纳,获得10
9秒前
高分求助中
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
Handbook of pharmaceutical excipients, Ninth edition 5000
Aerospace Standards Index - 2026 ASIN2026 3000
Signals, Systems, and Signal Processing 610
Discrete-Time Signals and Systems 610
Research Methods for Business: A Skill Building Approach, 9th Edition 500
Social Work and Social Welfare: An Invitation(7th Edition) 410
热门求助领域 (近24小时)
化学 材料科学 医学 生物 工程类 纳米技术 有机化学 物理 生物化学 化学工程 计算机科学 复合材料 内科学 催化作用 光电子学 物理化学 电极 冶金 遗传学 细胞生物学
热门帖子
关注 科研通微信公众号,转发送积分 6054153
求助须知:如何正确求助?哪些是违规求助? 7877046
关于积分的说明 16281878
捐赠科研通 5199385
什么是DOI,文献DOI怎么找? 2782062
邀请新用户注册赠送积分活动 1764916
关于科研通互助平台的介绍 1646354